Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0021 Transporter Info | ||||
| Gene Name | SLC15A1 | ||||
| Transporter Name | Peptide transporter 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Moxalactam Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 47499 | ||||
| Docking Score | -9.284 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C20H20N6O9S | ||||
| Molecular Weight | 520.5 | ||||
| Canonical SMILES |
CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)C(C4=CC=C(C=C4)O)C(=O)O)OC)OC2)C(=O)O
|
||||
| InChI |
InChI=1S/C20H20N6O9S/c1-25-19(22-23-24-25)36-8-10-7-35-18-20(34-2,17(33)26(18)13(10)16(31)32)21-14(28)12(15(29)30)9-3-5-11(27)6-4-9/h3-6,12,18,27H,7-8H2,1-2H3,(H,21,28)(H,29,30)(H,31,32)/t12?,18-,20+/m1/s1
|
||||
| InChIKey | JWCSIUVGFCSJCK-CAVRMKNVSA-N | ||||
| Pharmaceutical Properties | Xlogp | -0.6 | Rotatable Bond Count | 9 | |
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 13 | ||
| Xenobiotic Name | Cefsulodin Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 656575 | ||||
| Docking Score | -9.219 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C22H20N4O8S2 | ||||
| Molecular Weight | 532.6 | ||||
| Canonical SMILES |
C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)S(=O)(=O)O)C(=O)[O-])C[N+]4=CC=C(C=C4)C(=O)N
|
||||
| InChI |
InChI=1S/C22H20N4O8S2/c23-18(27)13-6-8-25(9-7-13)10-14-11-35-21-15(20(29)26(21)16(14)22(30)31)24-19(28)17(36(32,33)34)12-4-2-1-3-5-12/h1-9,15,17,21H,10-11H2,(H4-,23,24,27,28,30,31,32,33,34)/t15-,17-,21-/m1/s1
|
||||
| InChIKey | SYLKGLMBLAAGSC-QLVMHMETSA-N | ||||
| Pharmaceutical Properties | Xlogp | 0.2 | Rotatable Bond Count | 7 | |
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 9 | ||
| Xenobiotic Name | Valsartan Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 60846 | ||||
| Docking Score | -9.14 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C24H29N5O3 | ||||
| Molecular Weight | 435.5 | ||||
| Canonical SMILES |
CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O
|
||||
| InChI |
InChI=1S/C24H29N5O3/c1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23/h6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H,31,32)(H,25,26,27,28)/t22-/m0/s1
|
||||
| InChIKey | ACWBQPMHZXGDFX-QFIPXVFZSA-N | ||||
| Pharmaceutical Properties | Xlogp | 4.4 | Rotatable Bond Count | 10 | |
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 6 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.